Nanoplasmonic amplification in microfluidics enables accelerated colorimetric quantification of nucleic acid biomarkers from pathogens

T AbdElFatah, M Jalali, SG Yedire, I I. Hosseini… - Nature …, 2023 - nature.com
Deployment of nucleic acid amplification assays for diagnosing pathogens in point-of-care
settings is a challenge due to lengthy preparatory steps. We present a molecular diagnostic …

Multiplexed reverse-transcriptase quantitative polymerase chain reaction using plasmonic nanoparticles for point-of-care COVID-19 diagnosis

NR Blumenfeld, MAE Bolene, M Jaspan… - Nature …, 2022 - nature.com
Quantitative polymerase chain reaction (qPCR) offers the capabilities of real-time monitoring
of amplified products, fast detection, and quantitation of infectious units, but poses technical …

Ultrafast and real-time nanoplasmonic on-chip polymerase chain reaction for rapid and quantitative molecular diagnostics

BH Kang, Y Lee, ES Yu, H Na, M Kang, HJ Huh… - ACS …, 2021 - ACS Publications
Advent and fast spread of pandemic diseases draw worldwide attention to rapid, prompt,
and accurate molecular diagnostics with technical development of ultrafast polymerase …

Multiplexed and high-throughput label-free detection of RNA/spike protein/IgG/IgM biomarkers of SARS-CoV-2 infection utilizing nanoplasmonic biosensors

AN Masterson, BB Muhoberac, A Gopinadhan… - Analytical …, 2021 - ACS Publications
To tackle the COVID-19 outbreak, which is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), there is an unmet need for highly accurate diagnostic tests at …

Ultrafast plasmonic nucleic acid amplification and real-time quantification for decentralized molecular diagnostics

BH Kang, KW Jang, ES Yu, H Na, YJ Lee, WY Ko… - ACS …, 2023 - ACS Publications
Point-of-care real-time reverse-transcription polymerase chain reaction (RT-PCR) facilitates
the widespread use of rapid, accurate, and cost-effective near-patient testing that is …

RNA-extraction-free nano-amplified colorimetric test for point-of-care clinical diagnosis of COVID-19

M Alafeef, P Moitra, K Dighe, D Pan - Nature Protocols, 2021 - nature.com
The global pandemic of coronavirus disease 2019 (COVID-19) highlights the shortcomings
of the current testing paradigm for viral disease diagnostics. Here, we report a stepwise …

PD-LAMP smartphone detection of SARS-CoV-2 on chip

AJ Colbert, DH Lee, KN Clayton, ST Wereley… - Analytica Chimica …, 2022 - Elsevier
Abstract In 2019 the COVID-19 pandemic, caused by SARS-CoV-2, demonstrated the urgent
need for rapid, reliable, and portable diagnostics. The COVID-19 pandemic was declared in …

A point-of-care microfluidic biosensing system for rapid and ultrasensitive nucleic acid detection from clinical samples

Y Zhang, Y Song, Z Weng, J Yang, L Avery… - Lab on a Chip, 2023 - pubs.rsc.org
Rapid and ultrasensitive point-of-care RNA detection plays a critical role in the diagnosis
and management of various infectious diseases. The gold-standard detection method of …

Sample-to-answer COVID-19 nucleic acid testing using a low-cost centrifugal microfluidic platform with bead-based signal enhancement and smartphone read-out

RRG Soares, AS Akhtar, IF Pinto, N Lapins, D Barrett… - Lab on a Chip, 2021 - pubs.rsc.org
With its origin estimated around December 2019 in Wuhan, China, the ongoing SARS-CoV-
2 pandemic is a major global health challenge. The demand for scalable, rapid and …

Accessible detection of SARS-CoV-2 through molecular nanostructures and automated microfluidics

H Zhao, Y Zhang, Y Chen, NRY Ho, NR Sundah… - Biosensors and …, 2021 - Elsevier
Accurate and accessible nucleic acid diagnostics is critical to reducing the spread of COVID-
19 and resuming socioeconomic activities. Here, we present an integrated platform for the …